515120 创新药ETF
交易中 12-24 10:04:00
资讯
新帖
简况
【ETF动向】12月23日广发中证香港创新药ETF(QDII)基金跌0.28%,份额增加2.12亿份
证券之星 · 06:30
【ETF动向】12月23日广发中证香港创新药ETF(QDII)基金跌0.28%,份额增加2.12亿份
创新药ETF(159992)回调蓄力,机构:看好2025年医药行业投资机会
新浪基金 · 12-23 16:59
创新药ETF(159992)回调蓄力,机构:看好2025年医药行业投资机会
2025年多个国产创新药获批上市值得期待,关注创新药ETF(159992)投资机会
新浪基金 · 12-20
2025年多个国产创新药获批上市值得期待,关注创新药ETF(159992)投资机会
【ETF动向】12月19日广发中证香港创新药ETF(QDII)基金跌0.54%,份额增加1.57亿份
证券之星 · 12-20
【ETF动向】12月19日广发中证香港创新药ETF(QDII)基金跌0.54%,份额增加1.57亿份
【ETF动向】12月17日广发中证香港创新药ETF(QDII)基金跌0.14%,份额增加2.19亿份
证券之星 · 12-18
【ETF动向】12月17日广发中证香港创新药ETF(QDII)基金跌0.14%,份额增加2.19亿份
【ETF动向】12月16日广发中证香港创新药ETF(QDII)基金跌2.28%,份额增加2.04亿份
证券之星 · 12-17
【ETF动向】12月16日广发中证香港创新药ETF(QDII)基金跌2.28%,份额增加2.04亿份
【ETF动向】12月13日广发中证香港创新药ETF(QDII)基金跌2.36%,份额增加1.44亿份
证券之星 · 12-14
【ETF动向】12月13日广发中证香港创新药ETF(QDII)基金跌2.36%,份额增加1.44亿份
【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金涨1.06%,份额减少7300万份
证券之星 · 12-04
【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金涨1.06%,份额减少7300万份
行业ETF风向标丨创新药关注度升温,港股通创新药ETF半日涨幅近2%
每日经济新闻 · 12-03
行业ETF风向标丨创新药关注度升温,港股通创新药ETF半日涨幅近2%
【ETF动向】11月25日广发中证香港创新药ETF(QDII)基金涨1.53%,份额减少6150万份
证券之星 · 11-26
【ETF动向】11月25日广发中证香港创新药ETF(QDII)基金涨1.53%,份额减少6150万份
【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份
证券之星 · 11-19
【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份
【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份
证券之星 · 11-15
【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份
【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份
证券之星 · 11-13
【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份
证券之星 · 10-31
【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物
证券之星 · 10-25
广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物
【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份
证券之星 · 10-11
【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份
【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份
证券之星 · 10-09
【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份
【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份
证券之星 · 10-01
【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份
【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份
证券之星 · 09-24
【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份
ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%
市场透视 · 09-20
ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"515120","market":"SH","secType":"STK","nameCN":"创新药ETF","latestPrice":0.534,"timestamp":1735005840000,"preClose":0.532,"halted":0,"volume":36494000,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","marketStatusCode":2,"change":0.002,"latestTime":"12-24 10:04:00","open":0.53,"high":0.536,"low":0.53,"amount":19485300,"amplitude":0.0113,"askPrice":0.534,"askSize":5331,"bidPrice":0.533,"bidSize":103832,"shortable":0,"etf":1,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1735011000000},"adr":0,"adjPreClose":0.532,"symbolType":"fund","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":0.585,"lowLimit":0.479,"ibTradeSell":false,"ibTradeBuySell":true,"pbRate":0,"committee":0.084219,"marketValue":0,"floatMarketCap":0,"changeRate":0.0038,"turnoverRate":0,"status":0,"discountRate":"0.00%","netWorth":"0.000"},"requestUrl":"/m/hq/s/515120/wiki","defaultTab":"wiki","newsList":[{"id":"2493714531","title":"【ETF动向】12月23日广发中证香港创新药ETF(QDII)基金跌0.28%,份额增加2.12亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493714531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493714531?lang=zh_cn&edition=full","pubTime":"2024-12-24 06:30","pubTimestamp":1734993049,"startTime":"0","endTime":"0","summary":"证券之星消息,12月23日,广发中证香港创新药ETF(QDII)基金(513120)跌0.28%,成交额8.71亿元。当日份额增加了2.12亿份,最新份额为108.36亿份,近20个交易日份额增加10.1亿份。当日资金净流入1.62亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为77.26亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.52%,近一个月超额回报为-0.1%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122400006106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2493735032","title":"创新药ETF(159992)回调蓄力,机构:看好2025年医药行业投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2493735032","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493735032?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:59","pubTimestamp":1734944340,"startTime":"0","endTime":"0","summary":"12月23日,市场全天震荡走低,创新药ETF跌1.39%,成交额2.66亿元。成份股方面,十大重仓股涨跌互现。上涨方面,药明康德领涨;下跌方面,万泰生物领跌。 创新药ETF业绩比较基准为中证创新药产业指数,管理人为银华基金管理股份有限公司,基金经理为王帅、马君,成立以来回报为-28.02%,近一个月回报为-3.3%。本次集采共纳入62个品种、135个品规,申报企业439个,产品778个,首年约定采购额为85.13亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-12-23/doc-ineamxpt3781621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","515120"],"gpt_icon":0},{"id":"2492651514","title":"2025年多个国产创新药获批上市值得期待,关注创新药ETF(159992)投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2492651514","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492651514?lang=zh_cn&edition=full","pubTime":"2024-12-20 11:32","pubTimestamp":1734665520,"startTime":"0","endTime":"0","summary":"长江证券第二届长牛杯ETF实盘大赛火热报名中,点击链接立即参赛赢好礼! 12月20日,截止午间收盘,创新药ETF涨0.42%,报0.724元,成交额1.26亿元。创新药ETF重仓股方面,恒瑞医药截止午盘涨0.62%,药明康德涨0.61%,智飞生物涨1.22%,泰格医药涨0.08%,长春高新涨0.18%,科伦药业涨0.13%,复星医药涨0.08%,万泰生物涨1.25%,华东医药跌0.44%,康龙化成涨0.54%。 国投证券认为,2025年多个国产创新药获批上市值得期待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/aiassistant/etfwp/2024-12-20/doc-ineaarnt3144422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["515120","06978","BK1161","BK1574","159992"],"gpt_icon":0},{"id":"2492433638","title":"【ETF动向】12月19日广发中证香港创新药ETF(QDII)基金跌0.54%,份额增加1.57亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492433638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492433638?lang=zh_cn&edition=full","pubTime":"2024-12-20 06:30","pubTimestamp":1734647450,"startTime":"0","endTime":"0","summary":"证券之星消息,12月19日,广发中证香港创新药ETF(QDII)基金(513120)跌0.54%,成交额9.57亿元。当日份额增加了1.57亿份,最新份额为103.57亿份,近20个交易日份额增加4.89亿份。当日资金净流入2294.91万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为74.35亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.67%,近一个月超额回报为-0.15%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000003943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2492911863","title":"【ETF动向】12月17日广发中证香港创新药ETF(QDII)基金跌0.14%,份额增加2.19亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492911863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492911863?lang=zh_cn&edition=full","pubTime":"2024-12-18 06:30","pubTimestamp":1734474648,"startTime":"0","endTime":"0","summary":"证券之星消息,12月17日,广发中证香港创新药ETF(QDII)基金(513120)跌0.14%,成交额10.63亿元。当日份额增加了2.19亿份,最新份额为101.88亿份,近20个交易日份额增加2.52亿份。当日资金净流入1.38亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为72.86亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.32%,近一个月超额回报为0.15%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800005749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2492662110","title":"【ETF动向】12月16日广发中证香港创新药ETF(QDII)基金跌2.28%,份额增加2.04亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492662110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492662110?lang=zh_cn&edition=full","pubTime":"2024-12-17 06:30","pubTimestamp":1734388247,"startTime":"0","endTime":"0","summary":"证券之星消息,12月16日,广发中证香港创新药ETF(QDII)基金(513120)跌2.28%,成交额9.26亿元。当日份额增加了2.04亿份,最新份额为99.69亿份,近20个交易日份额增加5600万份。当日资金净流出2852.79万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.48亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.36%,近一个月超额回报为0.16%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700005591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2491581957","title":"【ETF动向】12月13日广发中证香港创新药ETF(QDII)基金跌2.36%,份额增加1.44亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2491581957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491581957?lang=zh_cn&edition=full","pubTime":"2024-12-14 06:30","pubTimestamp":1734129048,"startTime":"0","endTime":"0","summary":"证券之星消息,12月13日,广发中证香港创新药ETF(QDII)基金(513120)跌2.36%,成交额8.49亿元。当日份额增加了1.44亿份,最新份额为97.65亿份,近20个交易日份额减少7100万份。当日资金净流出5484.74万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.76亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.89%,近一个月超额回报为0.04%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121400006482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2488977445","title":"【ETF动向】12月3日广发中证香港创新药ETF(QDII)基金涨1.06%,份额减少7300万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488977445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488977445?lang=zh_cn&edition=full","pubTime":"2024-12-04 06:30","pubTimestamp":1733265049,"startTime":"0","endTime":"0","summary":"证券之星消息,12月3日,广发中证香港创新药ETF(QDII)基金(513120)涨1.06%,成交额10.91亿元。当日份额减少了7300万份,最新份额为96.87亿份,近20个交易日份额增加5.46亿份。当日资金净流入7405.24万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为73.99亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-17.79%,近一个月超额回报为-0.42%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400006027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2488959439","title":"行业ETF风向标丨创新药关注度升温,港股通创新药ETF半日涨幅近2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488959439","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488959439?lang=zh_cn&edition=full","pubTime":"2024-12-03 13:19","pubTimestamp":1733203140,"startTime":"0","endTime":"0","summary":" 今日上午,创新药板块整体较为强势,其中,港股通创新药ETF半日涨幅接近2%,是今日行业ETF中表现最为突出的品种。 点评:港股通创新药ETF和港股创新药ETF今日上午分别上涨1.81%和1.61%,其中,港股通创新药ETF规模较大,达到5.92亿份,其半日成交金额为3766万元,上述两只ETF均追踪的是国证港股通创新药指数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","FDN","HSCEI","BK4550","159992","HSTECH","BK4588","06978","BK4585","BK1161","515120","YANG"],"gpt_icon":1},{"id":"2486061300","title":"【ETF动向】11月25日广发中证香港创新药ETF(QDII)基金涨1.53%,份额减少6150万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486061300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486061300?lang=zh_cn&edition=full","pubTime":"2024-11-26 06:30","pubTimestamp":1732573849,"startTime":"0","endTime":"0","summary":"证券之星消息,11月25日,广发中证香港创新药ETF(QDII)基金(513120)涨1.53%,成交额9.71亿元。当日份额减少了6150万份,最新份额为98.26亿份,近20个交易日份额增加10.52亿份。当日资金净流入4330.18万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.42亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-15.66%,近一个月超额回报为0.69%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600005762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2484801509","title":"【ETF动向】11月18日广发中证香港创新药ETF(QDII)基金跌2.04%,份额增加7700万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2484801509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484801509?lang=zh_cn&edition=full","pubTime":"2024-11-19 06:30","pubTimestamp":1731969048,"startTime":"0","endTime":"0","summary":"证券之星消息,11月18日,广发中证香港创新药ETF(QDII)基金(513120)跌2.04%,成交额12.79亿元。当日份额增加了7700万份,最新份额为99.13亿份,近20个交易日份额增加11.54亿份。当日资金净流出1.01亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为70.91亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-18.42%,近一个月超额回报为-2.67%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900004695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2483535136","title":"【ETF动向】11月14日广发中证香港创新药ETF(QDII)基金跌1.6%,份额增加1.94亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483535136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483535136?lang=zh_cn&edition=full","pubTime":"2024-11-15 06:30","pubTimestamp":1731623447,"startTime":"0","endTime":"0","summary":"证券之星消息,11月14日,广发中证香港创新药ETF(QDII)基金(513120)跌1.6%,成交额11.76亿元。当日份额增加了1.94亿份,最新份额为98.27亿份,近20个交易日份额增加10.9亿份。当日资金净流入570.96万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为72.18亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.97%,近一个月超额回报为-0.73%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500004359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2483232069","title":"【ETF动向】11月12日广发中证香港创新药ETF(QDII)基金跌0.65%,份额增加2.52亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483232069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483232069?lang=zh_cn&edition=full","pubTime":"2024-11-13 06:30","pubTimestamp":1731450649,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日,广发中证香港创新药ETF(QDII)基金(513120)跌0.65%,成交额28.93亿元。当日份额增加了2.52亿份,最新份额为95.17亿份,近20个交易日份额增加7.8亿份。当日资金净流入1.8亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为73.07亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-17.6%,近一个月超额回报为-0.26%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300004624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2479606447","title":"【ETF动向】10月30日广发中证香港创新药ETF(QDII)基金跌3.45%,份额增加1.18亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2479606447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479606447?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:30","pubTimestamp":1730327449,"startTime":"0","endTime":"0","summary":"证券之星消息,10月30日,广发中证香港创新药ETF(QDII)基金(513120)跌3.45%,成交额17.32亿元。当日份额增加了1.18亿份,最新份额为90.06亿份,近20个交易日份额增加7.28亿份。当日资金净流出1.05亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为68.31亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-17.11%,近一个月超额回报为-0.99%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100008409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2478958256","title":"广发基金刘杰旗下广发中证香港创新药ETF(QDII)三季报最新持仓,重仓药明生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2478958256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478958256?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:52","pubTimestamp":1729871559,"startTime":"0","endTime":"0","summary":"证券之星消息,10月25日广发基金旗下刘杰管理的广发中证香港创新药交易型开放式指数基金(QDII)公布三季报,近1年净值增长率-1.93%。与上一季度相比,该基金前十大重仓股新增药明康德,金斯瑞生物科技;并对药明生物增仓298.85万股,为该基金第一大重仓股;再鼎医药,三生制药等退出前十大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500050733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0516422440.USD","02269","LU0359202008.SGD","515120","LU0039217434.USD","LU0326950275.SGD","LU0819121731.USD","LU0327786744.USD","LU0348735423.USD","LU2039709279.SGD","LU0456846285.SGD","LU0572944931.SGD","LU0051755006.USD","LU0140636845.USD","LU0516423091.SGD","LU1242518931.SGD","LU0516423174.USD","BK1589","BK1576","LU0979878070.USD","SG9999002463.SGD","BK1141","LU0307460666.USD","LU1794554557.SGD","LU0320764599.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0359201612.USD","BK1610","LU0823426480.USD","LU1880383366.USD","BK1521","LU1242518857.USD","LU0052750758.USD","LU0043850808.USD","LU0823426308.USD","LU0417516902.SGD","LU0856984785.SGD","SG9999002562.SGD","LU0588546209.SGD","LU0348825331.USD","LU1720050803.USD","LU1688375341.USD","LU0516422952.EUR","LU0417516738.SGD","LU0181495838.USD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"2474052705","title":"【ETF动向】10月10日广发中证香港创新药ETF(QDII)基金涨2.77%,份额减少1.48亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2474052705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474052705?lang=zh_cn&edition=full","pubTime":"2024-10-11 06:30","pubTimestamp":1728599447,"startTime":"0","endTime":"0","summary":"证券之星消息,10月10日,广发中证香港创新药ETF(QDII)基金(513120)涨2.77%,成交额37.44亿元。当日份额减少了1.48亿份,最新份额为87.78亿份,近20个交易日份额增加5.16亿份。当日资金净流出2155.41万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为71.84亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-18.51%,近一个月超额回报为-3.45%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100003651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2474128067","title":"【ETF动向】10月8日广发中证香港创新药ETF(QDII)基金涨2.77%,份额增加4.57亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2474128067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474128067?lang=zh_cn&edition=full","pubTime":"2024-10-09 06:30","pubTimestamp":1728426652,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日,广发中证香港创新药ETF(QDII)基金(513120)涨2.77%,成交额46.86亿元。当日份额增加了4.57亿份,最新份额为89.27亿份,近20个交易日份额增加7.73亿份。当日资金净流入6.32亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为74.44亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-14.15%,近一个月超额回报为3.81%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900002550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2472363770","title":"【ETF动向】9月30日广发中证香港创新药ETF(QDII)基金涨9.78%,份额增加1.9亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2472363770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472363770?lang=zh_cn&edition=full","pubTime":"2024-10-01 06:30","pubTimestamp":1727735452,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日,广发中证香港创新药ETF(QDII)基金(513120)涨9.78%,成交额48.27亿元。当日份额增加了1.9亿份,最新份额为84.71亿份,近20个交易日份额增加1.48亿份。当日资金净流入5.08亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为68.12亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-16.91%,近一个月超额回报为-0.38%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100008854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2469745331","title":"【ETF动向】9月23日广发中证香港创新药ETF(QDII)基金跌0.15%,份额增加1.14亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2469745331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469745331?lang=zh_cn&edition=full","pubTime":"2024-09-24 06:30","pubTimestamp":1727130658,"startTime":"0","endTime":"0","summary":"证券之星消息,9月23日,广发中证香港创新药ETF(QDII)基金(513120)跌0.15%,成交额13.56亿元。当日份额增加了1.14亿份,最新份额为81.17亿份,近20个交易日份额减少4.26亿份。当日资金净流出7056.36万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为54.86亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-13.9%,近一个月超额回报为0.16%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400004089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2468666648","title":"ETF午盘|各ETF跌多涨少 创新药ETF跌逾2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468666648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468666648?lang=zh_cn&edition=full","pubTime":"2024-09-20 11:35","pubTimestamp":1726803330,"startTime":"0","endTime":"0","summary":"ETF方面,各ETF跌多涨少,黄金股ETF、房地产ETF、地产ETF等涨幅居前,分别涨2.24%、涨2.04%、涨1.83%;创新药ETF、国防军工ETF、半导体设备ETF等跌幅居前,分别跌2.3%、跌2.15%、跌2.13%;华宝添益ETF、银华日利ETF、短融ETF等成交额居前,分别成交51.3亿元、成交41.04亿元、成交38.39亿元。分品种来看,今日主题ETF表现优于行业ETF及跨境ETF,其中黄金股ETF基金涨2.49%、计算机ETF南方涨1.99%、教育ETF涨1.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201135149570c2a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201135149570c2a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["515120","561980"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0185},{"period":"1month","weight":0.0019},{"period":"3month","weight":0.1667},{"period":"6month","weight":0.1247},{"period":"1year","weight":-0.1119},{"period":"ytd","weight":-0.1364}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"serverTime":1735005856160,"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药ETF,515120,创新药ETF股票,创新药ETF股票老虎,创新药ETF股票老虎国际,创新药ETF行情,创新药ETF股票行情,创新药ETF股价,创新药ETF股市,创新药ETF股票价格,创新药ETF股票交易,创新药ETF股票购买,创新药ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}